The VITA Project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism

British Journal of Haematology

Volumn 97, Issue 4, 1997, Pages 804-806

  Tosetto, Alberto ^a   Missiaglia, Edoardo ^a   Frezzato, Maurizio ^a   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Epidemiological studies; Hyperhomocysteinaemia; Thrombophilia; Venous thromboembolism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 0030844717     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.1422957.x     Document Type: Article

References (12)

1. Cattaneo, M., Tsai, M.Y., Bucciarelli, P., Taioli, E., Zighetti, M.L., Bignell, M. & Mannucci, P.M. (1996) A common mutation in the methylene-tetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V: Q506). Blood, 88, 285a.
2. den Heijer, M., Blom, H.J., Gerrits, W.B., Rosendaal, F.R., Haak, H.L., Wijermans, P.W. & Bos, G.M.J. (1995) Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis. Lancet, 345, 882-885.
3. den Heijer, M., Koster, T., Blom, H.J., Bos, G.M.J., Briet, E., Reitsma, P.H., Vandenbroucke, J.P. & Rosendaal, F.R. (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. New England Journal of Medicine, 334, 759-762.
4. Engbersen, A.M.T., Franken, D.G., Boers, G.H., Stevens, E.M.B., Trijbels, F.J.M. & Blom, H.J. (1995) Thermolabile 5,10-methylene-tetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. American Journal of Human Genetics, 56, 142-150.
5. Falcon, C.R., Cattaneo, M., Panzeri, D., Martinelli, I. & Mannucci, P.M. (1994) High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arteriosclerosis and Thrombosis, 14, 1080-1083.
6. Frezzato, M., Tosetto, A. & Rodeghiero, F. (1996) Validated questionnaire for the identification of previous personal or familial venous thromboembolism. American Journal of Epidemiology, 143, 1257-1265.
7. Frezzato, M., Tosetto, A., Vicentini, S. & Rodeghiero, F. (1995) Prevalence of venous thromboembolism (VT) in active population: an update of the VITA (Viruses Thrombophilia and Arteriosclerosis) Project. Thrombosis and Haemostasis, 73, 951.
8. Frosst, R., Illorn, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Loers, G.J.H., den Heijer, M., Kluijtmans, L.A.J., van den Heuvel, L.P. & Rozen, R. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylene-tetrahydrofolate reductase. Nature Genetics, 10, 111-113.
9. Goyette, P., Frosst, P., Rosenblatt, D.S. & Rozen, R. (1995) Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. American Journal of Human Genetics, 56, 1052-1059.
10. Kluijtmans, L.A.J., van den Heuvel, L.P., Boers, G.H., Frosst, P., Stevens, E.M.B., van Oost, B.A., den Heijer, M., Trijbels, F.J.M., Rozen, R. & Blom, H.J. (1996) Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylene-tetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. American Journal of Human Genetics, 58, 35-41.
11. Mandel, H., Brenner, B., Berant, M., Rosenberg, N., Lanir, N., Jakobs, C., Fowler, B. & Seligsohn, U. (1996) Coexistence of hereditary homocysteinuria and factor V Leiden: effect on thrombosis. New England Journal of Medicine, 334, 763-768.
12. Rodeghiero, F. & Tosetto, A. (1996) The VITA Project: population-based distribution of protein C, antithrombin III, heparin cofactor II and plasminogen: relationship with physiological variables and establishment of reference ranges. Thrombosis and Haemostasis, 76, 226-233.